Precaution and equivalence - the critical interplay in EU biotech foods

Petetin, Ludivine ORCID: https://orcid.org/0000-0001-9853-477X 2017. Precaution and equivalence - the critical interplay in EU biotech foods. European Law Review 42 (6) , pp. 831-847.

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial. Download (565kB)

Abstract

Scientific uncertainty surrounds biotech foods. To regulate such foods and to ensure consumer choice and safety, the EU has adopted a precautionary approach based on premarket authorization and mandatory labelling. Despite these regulatory requirements, the controversial concept of substantial equivalence is still present within the existing regimes for GM and cloned foods. The concept uses a comparative analysis of conventional and biotech foods to assess their safety. If substantial equivalence is present, biotech foods are regulated in the same manner as conventional foods. The concept restricts consumer choice and calls into question the safety of such foods because it requires no specific mandatory labelling or traceability and only minimal premarket authorization. The dynamic between substantial equivalence and the precautionary principle is problematic as the two concepts seem contradictory. This situation prevents the existence of an adequate and efficient regulatory environment for EU biotech foods regulation and undermines a comprehensive precautionary approach towards such foods and the EU food system in general.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Cardiff Law & Politics Law
Subjects:	K Law > K Law (General)
Publisher:	Sweet and Maxwell
ISSN:	0307-5400
Date of First Compliant Deposit:	11 July 2017
Date of Acceptance:	6 June 2017
Last Modified:	13 Nov 2024 16:15
URI:	https://orca.cardiff.ac.uk/id/eprint/102253

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item